CCOA Therapeutics Inc

5 enregistrements totalisant 290,064.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.

Intégrer ce graphique

Par ministère

Conseil national de recherches Canada $290,064 5 enregistrements

Enregistrements

CCOA Therapeutics Inc $100,982.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
EF 2020-2021
Canada

The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.

CCOA Therapeutics Inc $71,148.00
National Research Council Canada | Conseil national de recherches Canada
Innovation Assistance Program
EF 2020-2021
Canada

The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.

CCOA Therapeutics Inc $50,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2020-2021
Canada

The project is to develop global regulatory strategy for therapeutics, in vitro diagnostics, natural health products, and laboratory research reagents of CCOA Therapeutics (CCOA). This strategy will a...

CCOA Therapeutics Inc $37,934.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
EF 2020-2021
Canada

The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.

CCOA Therapeutics Inc $30,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Youth Employment Program
EF 2020-2021
Canada

This project is to develop community-based prophylaxis for COVID-19 via our newly developed Angiotensin-Converting Enzyme 2 (ACE2) mimetics, and to develop marketing strategy for our innovative produc...